April Eye Care News
Katena Products, Inc. have acquired fellow #surgical instrument manufacturer ASICO LLC. According to Katena's CEO Steve Blazejewski the deal 'provides Katena increased reach globally, capitalising on Asico's network of renowned KOLs'.
ProQR Therapeutics have published clinical trial data describing durable vision improvement after treatment with sepofarsen for Mediated Leber Congenital Amaurosis. LCA is the most common cause of blindness due to genetic disease in children. The #RNA therapy is applied via intravitreal injection into the retina and the results “indicate that RNA therapy could potentially be used to treat early stage disease” according to CMO Aniz Girach, MD.
Johnson & Johnson Vision & Menicon have announced a collaboration to develop contact lenses to manage #myopia in children. The deal means Menicon will manufacture the lenses and J&J will distribute them. Together they aim to increase the global availability of their myopia products.
Sticking with the theme of myopia in children, Essilor Group have released pivotal 2-year clinical trial results of its Stellest lens for myopia. The results reveal that the lenses slow down myopia progression by 67% on average, when compared to single vision lenses.
James Pickering is our Managing Director and an eye care recruitment expert who has developed an extensive client base and candidate network. He regularly writes articles about industry developments and has received numerous recommendations from industry leaders. You can also connect with James on LinkedIn to stay up to date on the latest eye care news.